Modalis Therapeutics Corporation
Monthly Exercise Status of the 19th Stock Acquisition Rights Issued through a Third-Party Allotment (Exercise Price Adjustment Clause) – Notice
Discloses the monthly exercise status for stock acquisition rights (19th). For the target month, number of issued shares is 7,040,000 shares; stock options exercised in July are 70,400 units (out of 240,000 issued units, 29.3%); unexercised rights at the end of the previous month were 230,000, and at month-end 159,600. Exercise restrictions: 7.3%.
Key Figures
- 7,040,000 shares: Target month issued shares
- 70,400 units: Monthly exercised stock acquisition rights
- 29.3%: Exercise ratio to issued shares
AI要約
Overview
This notice provides details of the monthly exercise status for the 19th stock acquisition rights issued via third-party allotment as of July 2026, disclosed on June 12, 2026. The target number of awarded shares is 7,040,000; stock options exercised in July amount to 70,400 units, and the exercise ratio to issued shares is 29.3%. Unexercised rights at the end of the previous month were 230,000, and at month-end were 159,600. The compliance with exercise restrictions stands at 7.3%.
Impact and Outlook
The exercise status of stock options may entail some dilution, but the current monthly data do not indicate any specific monetary impact. There are periods with a high exercise ratio relative to issued shares, which could lead to changes in the total number of shares depending on future exercise trends. Details on the financial impact remain unknown and additional disclosure is awaited.
Modalis, Inc.
Company overview · Stock price · Financial data · All IR
